Concord Drugs Ltd — Board Meeting, 30-06-2025: Board Meeting

Concord Drugs Limited has announced a board meeting to consider increasing its authorized capital and altering the Memorandum of Association. The board will also evaluate raising funds for business expansion through preferential allotment or other permissible methods, subject to approvals. Additionally, the meeting will decide on convening an Extra-Ordinary General Meeting to obtain shareholders’ approval for these proposals. This fund-raising plan aims to support the company’s growth initiatives.